HEALTH TECHNOLOGY

Atos and Huma Form a Five-Year Partnership to Improve Healthcare and Research with Innovative Remote Monitoring Technologies

Atos | June 07, 2021

Atos and Huma, a digital health innovator, has announced a five-year strategic global partnership to move healthcare and clinical trials out of hospitals and people's homes. The partnership will center on Huma's modular platform, which can power digital "home hospitals" nationally and assist pharmaceutical and research industries in running sophisticated worldwide, decentralized clinical trials. The platform is already being used in the United States and Europe to treat illnesses ranging from atrial fibrillation to diabetes to Covid-19.

 

To accelerate the adoption of Huma's technology, Atos will use its experience in delivering and scaling complex transformation projects. Atos will make an investment of up to 20 million in R&D and go-to-market resources, including dedicated consulting and sales personnel. The R&D investment will accelerate the integration of the Huma platform with other leading clinical platforms and develop a dedicated video module.

 

The immense pressure put on the world's healthcare systems by the Covid-19 pandemic exposes the flaws of current models, which are already overloaded aging populations and the increased worldwide incidence of chronic conditions. To improve both patient care and the entire efficiency of the care chain, innovation is required. The approach used by Atos and Huma means that patients are monitored outside of the hospital and get early, proactive clinical intervention ahead of need, ultimately optimizing resource use, improving patient outcomes, and reducing long-term healthcare costs.

 

Early evidence suggests that Huma's service, which is now available nationally in Germany, England, and the UAE, can almost double hospital capacity.

 

The partnership will use Huma's industry-leading software platform and 40+ patents and Atos' extensive professional service capabilities in digital strategy, change management, and service management.

 

The 5-year partnership will begin with integration, enabling global go-to-market deployments. Still, it will also combine Atos' expertise in promoting digital adoption, support, and infrastructure with Huma's digital care, clinical trials, and biomarkers. The companies estimate that the combined service will generate 100 million in revenue per year during the first four years.

 

About Atos

With 105,000 employees and annual revenue of more than 11 billion, Atos is a global leader in digital transformation. The Group, the European leader in cybersecurity, cloud, and high-performance computing, provides customized end-to-end solutions for all industries in 71 countries. Atos, a pioneer in decarbonization services and products, is dedicated to providing its clients with a safe and decarbonized digital experience. Atos is recognized by the brands Atos and Atos|Syntel. 

 

About Huma

Huma is a global health technology company that helps people to live longer and more fulfilling lives. Our modular platform enables digital 'hospitals at home' in a variety of disease areas. We power some of the world's most extensive decentralized clinical trials and studies in life sciences. To promote proactive, predictive care and research, our platform combines artificial intelligence, digital biomarkers, and real-world data.

Spotlight

The importance technology plays in radiology which is key to supporting the model and infrastructure of seamless care. Philips has aided The University of Vermont Health Network in acquiring the most sophisticated equipment in the world, allowing them to offer the best clinical service and care to their patients.

Spotlight

The importance technology plays in radiology which is key to supporting the model and infrastructure of seamless care. Philips has aided The University of Vermont Health Network in acquiring the most sophisticated equipment in the world, allowing them to offer the best clinical service and care to their patients.

Related News

HEALTH TECHNOLOGY

Apixio's New Prospective Risk Adjustment Solutions Surface Actionable Insights to Improve Risk Capture & Clinical Guidance

Apixio | August 31, 2021

Apixio, the AI healthcare analytics company, today announced the launch of two advanced prospective solutions, Apicare Insights and Apicare Pre-Visit. These solutions leverage Apixio's Best in KLAS Risk Adjustment & Analytics technology to deliver a complete and accurate view of the patient and provide clinicians with actionable insights when and where it matters most, at the point-of-care. In the era of value-based care, healthcare organizations need a prospective risk adjustment program that empowers clinicians at the point of care, meets compliance mandates, and improves patient outcomes. Achieving these goals requires access to complete and accurate patient data. Access to this data is challenging for many reasons, including: Clinical and administrative data is stored in various siloes, and unstructured data is difficult to access and derive insights from in an efficient manner. Apixio's Apicare Insights and Apicare Pre-Visit solutions now allow payers and risk-bearing provider groups to empower clinicians with complete and accurate insights into a patient's longitudinal medical record. Apixio's prospective solutions enable healthcare organizations to increase risk capture, improve clinical guidance, and measure value-based care performance by providing high-confidence AI-powered insights. These prospective solutions leverage AI analytics to identify diagnosis gaps and surface suspected and recaptured conditions. With Apicare Pre-Visit, clinical reviewers have access to patient longitudinal medical records and can surface unconfirmed conditions with evidence-based insights within documents no matter their origin. This AI-assisted workflow allows clinical reviewers to ensure a more complete and accurate patient record. EHR Integration through Apixio's Infostream is available to providers, enabling them a bi-directional data exchange and the ability to push actionable insights right at the point of care. Apixio's experience has demonstrated that having AI and clinical reviewers working in tandem results in higher provider acceptance rates, fewer risk gaps, and ultimately, fewer dollars wasted. "In most EHRs, the process of reviewing each patient's medical records requires clinical staff to review a myriad of different tabs and multiple unstructured documents, including dozens of paper records, leading to potentially lost information," said Apixio's CEO Sachin Patel. "With these prospective solutions, Apixio does the heavy lifting for you, taking you straight to the insights that matter with the references and information you need to feel confident in the diagnoses and documentation." With Apixio's prospective solutions, organizations can: Uncover suspect and known conditions using Apixio's AI algorithms to improve risk score capture, diagnosis recapture, and documentation; Improve operational efficiency by reducing the time and resources spent aggregating and analyzing disparate patient data; Track and measure risk gap closures and recognize risk-related revenue earlier in the payment year to improve financial performance. About Apixio Apixio is advancing healthcare with data-driven intelligence and analytics. Our Artificial Intelligence platform gives organizations across the healthcare spectrum the power to mine clinical information at scale, creating novel insights that will change the way healthcare is measured, care is delivered, and discoveries are made.

Read More

HEALTH TECHNOLOGY

Sentinel U® Introduces Sentinel City® v.5 Community and Population Health Virtual Simulation

Sentinel U | August 17, 2021

Sentinel U®, a provider of web-based simulation education technology solutions for nursing schools, hospital systems and healthcare professionals, has upgraded its award-winning public health virtual simulation to an even more user-friendly and intuitive learning experience. Designed for nursing learners and educators, Sentinel City® v.5 offers a full suite of engaging and authentic scenarios intended to challenge nursing students and prepare them to be successful in their academic studies. The enhanced online learning platform incorporates virtual urban locations, data, and demographics designed to help nursing students develop advanced observation techniques, cultivate critical thinking skills, and practice professional caring of a patient population – all in a risk-free learning environment. "We are committed to furthering the role of virtual simulation education and Sentinel City® v.5 will solidify our place as a market leader," said Jeffrey Caplan, president of Sentinel U®. "The upgraded technology and additional content offers an unparalleled user experience, incorporating more than 100 comprehensive data sets compiled from real-world analytics community public health nurses encounter daily." Sentinel City® v.5 provides students with immersive encounters in which to practice and assess their community health nursing skills – but at a much deeper level. Students will now interact with ten additional citizens and communicate with two more key informant avatars as they enter and explore new locations within the city, as well as brand-new suburban neighborhood. Sentinel City® v.5 boasts diverse neighborhoods that provide learners the unique opportunity to interact with a wider demographic of patients – from geriatric to pediatric – and from different socio-economic levels. The result is a significantly enhanced community health learning program. Navigating these experiences has also improved. A new narrated bus tour, similar to a hop on-hop off bus tour, offers nursing students the opportunity to explore different businesses, services, and neighborhoods while engaging with citizens and key informant avatars. Nursing educators will appreciate the new web-based, searchable assignment catalog. Sentinel City® v.5 includes intuitive enhancements that allow educators to seamlessly align or adapt assignments to meet specific course outcomes or competencies. With a 34 percent increase in activities, Sentinel City® v.5 provides instructors with a plethora of community health experiences in areas such as physical environment, health and social services, safety, transportation, education, recreation, government, and communication. "Knowing our simulation commonly maps to Community or Population Health Nursing courses, our team has identified crosswalks to ensure a seamless transition to the new version," said Dr. Laura Gonzalez, vice president of clinical learning resources at Sentinel U®. Sentinel U® will host a webinar on Tuesday, August 24 at 11 a.m. EDT, where an expert panel will explain the virtues of the new version, outline available curriculum crosswalks, and detail Sentinel U®'s support for nursing educators throughout the transition process. Dr. Gonzalez will be joined by Sentinel U® Director of Empowered Classroom Melissa Penner, DNP, RN, CNE, and Director of Nursing Content Sabrina Cook, DNP, RN. The trio will answer questions about the new content and how it aligns with current curriculum standards. Sentinel U® is now available at the same subscription rate as Sentinel City® v.3 – $99 per student. Bundling options with additional simulations, such as Sentinel Town®, begin at only $119 per student. ABOUT Sentinel U® Sentinel U®, formerly Healthcare Learning Innovations, strives to meet the evolving needs of healthcare education and training by providing simulation-based technologies and digital learning tools. Sentinel U, a division of American Sentinel College of Nursing & Health Sciences at Post University, with 20 years of online education experience, offers virtual simulations and clinicals for nursing degree programs, hospital systems and healthcare facilities around the world.

Read More

FUTURE OF HEALTHCARE

Capital Rx Is Chosen by WTW to Join Its Rx Collaborative as a New PBM Partner

Capital Rx | April 21, 2022

WTW's Rx Collaborative has picked Capital Rx as a new, disruptive pharmacy benefits management partner. Capital Rx is a healthcare technology firm that is revolutionizing the way prescription pharmaceuticals are priced, and patients are served. Employers will have access to Capital Rx's cutting-edge technology and services through this new RxC partner. WTW launched a comprehensive search to find a new, innovative PBM to provide an alternative to the standard PBM model in response to growing employer dissatisfaction with escalating prescription drug costs. Capital Rx was chosen for its innovative medicine pricing strategy and flexible business model. WTW's aim of increasing transparency in PBM pricing and revenue sources while providing considerable financial benefit to employers is carried out in part via Capital Rx. "WTW's selection of Capital Rx is further validation of our mission to disrupt the traditional pharmacy benefits model and help employers gain more control over their prescription drug costs," said Matt Gibbs, President of Capital Rx. We're looking forward to engaging with self-funded employer clients to offer a new and different option. Through this partnership, Capital Rx remains true to our mission and extends the reach of our Clearinghouse Model to hundreds of new employers." As the fastest-growing PBM in the United States, Capital Rx offers a prescription drug pricing arrangement that reflects transparent, competitive costs for all. Capital Rx's groundbreaking Clearinghouse Model® leverages National Average Drug Acquisition Cost (NADAC), bringing visibility into actual drug unit costs and eliminating arbitrary price variability. Capital Rx's cloud-based enterprise pharmacy platform JUDI™ provides employers with significant financial savings, greater plan flexibility, and advanced reporting capabilities. "As the largest consultant led pharmacy purchasing coalition in the U.S., we strive to provide employers with access to the most innovative prescription benefits options in the marketplace, even if it means departing from more common PBM models. With its mission to deliver transparent drug pricing, Capital Rx has already delivered millions of dollars in prescription drug savings to its fast-growing roster of clients." Jasmine Aral, Rx Collaborative Team Lead, WTW This year, Capital Rx will participate in the RxC's new bid and renewal processes.

Read More